Results 111 to 120 of about 64,314 (239)

Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study

open access: yesBMC Musculoskeletal Disorders, 2004
Background Variability in dosing and costs of biologics among patients with rheumatoid arthritis (RA) is of interest to healthcare descision-makers.
Smith Daniel   +2 more
doaj  

Etanercept Enhances Preservation of Osteochondral Allograft Viability

open access: yes, 2011
Background: Osteochondral allografts are an increasingly popular treatment for the repair of articular cartilage lesions. Current tissue bank protocols require bacteriological testing that takes from 21 to 28 days to process.
William D. Bugbee   +5 more
core   +1 more source

Risk of cancer in psoriasis patients treated with biologic therapy: A BADBIR cohort study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
No evidence of an increased risk of incident cancer or KC was observed with biologic versus non‐biologic systemic therapies or across the biologic classes evaluated. Abstract Background There are concerns that biologic therapies for psoriasis may increase cancer risk. Objectives To compare risks of (i) incident cancer excluding keratinocyte carcinomas (
Oras A. Alabas   +9 more
wiley   +1 more source

Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial

open access: yesPediatric Rheumatology Online Journal
Background Etanercept has been studied in doses up to 0.8 mg/kg/week (max 50 mg/week) in juvenile idiopathic arthritis (JIA) patients. In clinical practice higher doses are used off-label, but evidence regarding the relation with outcomes is lacking.
Bastiaan T. van Dijk   +10 more
doaj   +1 more source

Etanercept: An Evolving Role in Psoriasis and Psoriatic Arthritis

open access: yes, 2010
Tumor necrosis factor alpha (TNFα) plays a key pathophysiological role in psoriasis and psoriatic arthritis (PsA). Recent interest has thus focused on the clinical potential of TNFα antagonists (e.g. etanercept) in these settings.
Prodanovich, Srdjan   +11 more
core   +1 more source

Periodontitis and Diabetes: Mechanistic Evidence of a Circular Relationship

open access: yesJournal of Periodontal Research, EarlyView.
This narrative review aimed to explore the underlying mechanisms that connect periodontitis to diabetes (and vice versa) and that influence disease susceptibility, progression and response to treatment. ABSTRACT The circular relationship between periodontitis and diabetes mellitus is one of the most established oral‐systemic links.
Philip M. Preshaw   +4 more
wiley   +1 more source

Etanercept combined with methotrexate for high-need psoriasis.

open access: yes, 2008
Contains fulltext : 70381.pdf (Publisher’s version ) (Open Access)BACKGROUND: For some high-need psoriatic patients, the efficacy of etanercept monotherapy is insufficient. In these cases it might be indicated to combine etanercept with
Jong, E.M.G.J. de   +5 more
core   +1 more source

Interim Update on Reactive Infectious Mucocutaneous Eruption (RIME)

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Reactive infectious mucocutaneous eruption (RIME), a term describing blistering skin and mucosal lesions, is a term coined by a group of Pediatric Dermatology Research Alliance (PeDRA) researchers and first published in 2021. Since that time, the literature has grown with reports of diverse infectious triggers, management strategies, and ...
Michele Ramien   +11 more
wiley   +1 more source

Effect of etanercept on cardiac function.

open access: yes, 2014
(A) The effect of etanercept on LVEF. (B) The effect of etanercept on LVEDP. (C) The effect of etanercept on –dp/dx max. (D) The effect of etanercept on +dp/dx max.
Mei Yang (51996)   +3 more
core   +1 more source

Periodontitis and rheumatoid arthritis—Global efforts to untangle two complex diseases

open access: yesPeriodontology 2000, EarlyView.
Abstract Understanding the impact of oral health on rheumatoid arthritis (RA) will inform how best to manage patients with both periodontitis and RA. This review seeks to provide an update on interventional and mechanistic investigations, including a brief summary of European Research programs investigating the link between periodontitis and RA. Recent
Isabel Lopez‐Oliva   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy